AL-3778

· Alios Biopharma Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AL-3778, covering 2017-10-16 to 2017-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects [Phase 2]